St Jude CE marks "smallest" implantable cardiac monitor
This article was originally published in Clinica
Executive Summary
St Jude Medical has CE marked its SJM Confirm device for sale in Europe for the detection of atrial fibrillation and other abnormal heart rhythms. The company claims it is the smallest implantable cardiac monitor available, about the size of a computer USB drive. It is implanted subcutaneously in the upper chest, an outpatient procedure which can be carried out under local anaesthetic. St Paul, Minnesota-based St Jude says the device can detect small and wide-ranging signals, therefore recording events associated with syncope and other arrhythmias which can be difficult to distinguish with other methods. It can also send data over the telephone line.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.